Subscribe To
Arvinas to Present at Stifel Targeted Oncology Day
NEW HAVEN, Conn., April 21, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Ian Taylor, Ph.D., Chief Scientific Officer, and Sean Cassidy, Chief Financial Officer, will participate in a fireside at the Stifel Targeted Oncology Day on […] The post Arvinas to Present at Stifel Targeted Oncology Day appeared first on ForexTV...
Read More
Posted: Apr 21 2023, 20:00
Author Name: forextv
Views: 082092